Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues

Keyphrases

• Conjugation 100%
• Gonadotropin-releasing Hormone 100%
• Photosensitizer 100%
• Receptor Targets 100%
• Protoporphyrin IX (PpIX) 71%
• Gonadotropin-releasing Hormone Receptor (GnRHR) 57%
• Cancer Cells 28%
• Phototoxicity 28%
• Gonadotropin-releasing Hormone Antagonist 28%
• Condensation 14%
• In Vitro Activity 14%
• Agonistic Behavior 14%
• Receptor-mediated 14%
• Malignant Cells 14%
• Plasma Parameters 14%
• Binding Affinity 14%
• Rat pituitary 14%
• Photodynamic Therapy 14%
• Homogeneous Solution 14%
• Pituitary Gonadotropins 14%
• Pituitary 14%
• Co-incubation 14%
• Phototoxic 14%
• Pituitary Gland 14%
• Benzotriazole 14%
• Pituitary Gonadotropes 14%
• Exogenous Gonadotropins 14%
• Desensitization 14%
• Hexafluorophosphate 14%
• Gonadotrope 14%
• LH Concentration 14%
• Serum LH 14%
• Antagonistic Activity 14%
• MCF-7 Cancer Cell Line 14%
• Rat Serum 14%
• Photodamage 14%
• MCF-7 Cells 14%
• Coupling Agent 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Protoporphyrin IX 100%
• Receptor-Mediated Targeting 100%
• Photosensitizer 100%
• Gonadorelin Derivative 100%
• Gonadorelin 60%
• Gonadorelin Receptor 60%
• Phototoxicity 40%
• Gonadorelin Agonist 40%
• Gonadorelin Antagonist 40%
• Photodynamic Therapy 20%
• Desensitization 20%
• Hexafluorophosphate 20%
• Breast Cancer 20%
• Malignant Neoplasm 20%
• Receptor 20%
• Releasing Factor 20%
• Gonadotropin 20%
• Hormone Receptor 20%